Photocure ASA

Photocure to Present at Two Healthcare-Focused Investor Conferences in April

Press Release - Oslo, Norway, 6 April 2021, Photocure ASA (OSE: PHO), The

Bladder Cancer Company, announces that President and Chief Executive Officer,

Daniel Schneider and Chief Financial Officer, Erik Dahl are scheduled to present

corporate overviews at two upcoming Healthcare Conferences in April.

Presentation details are as follows:

Solebury Trout European Biotech Investor Day: on April 7, 2021, Photocure

presents at 7:30pm CET / 1:30pm ET followed by individual investor meetings.

This virtual conference sponsored by Goodwin, Solebury Trout, Deutsche Bank and

NASDAQ showcases European biotech & healthcare companies.

You can sign up for the webcast

here (https://showroom.troutaccess.com/app?iframe=1#/webcast/HQ97XB).

Needham Annual Healthcare Conference: on April 15, 2021, Photocure presents at

2:45pm CET / 8:45am ET followed by individual investor meetings. This 20[th]

annual conference is sponsored by the U.S. bank Needham & Company.

Access to the live event/webcast is available

here (https://wsw.com/webcast/needham107/pho.ol/2530528Photocure).

For further information, please contact:

Dan Schneider

President and CEO

Photocure ASA

Tel: + 1-609 759-6515

Erik Dahl

Chief Financial Officer

Tel: +47 450 55 000

David Moskowitz

Head of Investor Relations

Tel: +1 202 280 0888

Media Enquiries:

Geir Bjørlo

Corporate Communications (Norway)

Tel: +47 91540000

About Photocure

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

AI Terminal